Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.
UAE President calls for stronger global cooperation at G7 Summit
UAE foils drug distribution plot, dismantles criminal network
Sharjah Ruler unveils AED 750 million projects to link direct roads to Dubai
UAE President meets US President on sidelines of G7 Summit
UAE President, Greek PM discuss strategic cooperation
Emirati Media Forum to address misinformation, AI and industry transformation
UAE introduces new Emiratisation rules for healthcare sector
